We use cookies to improve site performance and enhance your user experience. If you'd like to disable cookies on this device, please see our cookie management page.
If you close this message or continue to use this site, you consent to our use of cookies on this devise in accordance with our cookie policy, unless you disable them.



Your filtered view of the latest news and analysis

  • Tiziana shares soar

    05 October 2015

    Shares in cancer drug developer Tiziana Life Sciences have soared since their IPO last year.
  • Woodford piles into Silence

    01 October 2015

    Silence Therapeutics raised £40m earlier this year, bringing investor heavyweight Neil Woodford into the fold
  • Circassia NED takes profits

    01 October 2015

    Circassia director earns close to £2.5m after selling down stake in allergy specialist
  • Healthcare, profits and politics

    30 September 2015

    Profits in healthcare is a contentious topic. Should investors be worried about Hillary Clinton's war of words?
  • Vernalis launches in US

    29 September 2015

    Cough and cold specialist Vernalis has launched its first product in the lucrative US market
  • hVivo numbers disappoint

    25 September 2015

    Lower-than-expected revenues from Aim-listed hVivo sent the shares tumbling
  • Clinigen inks latest deal

    23 September 2015

    Clinigen has gained access to a number of new markets through its latest acquisition
  • Horizon's top line soars Tip Update

    22 September 2015

    Sales at Horizon Discovery took off although the company said it still had a growth agenda
  • Allergy Therapeutics resumes US push

    22 September 2015

    Having raised £20m in March, vaccine specialist Allergy Therapeutics has resumed clinical trials in the US
  • The German question

    11 September 2015

    The euro crisis has abated but it will return, once more focusing attention on the shortcomings of Germany’s economic model
  • Back to school after biotech blip

    10 September 2015

    It's business as usual as two more healthcare companies gear up to make their debut in London
  • Alliance Pharma back in the game

    09 September 2015

    After years of share price inactivity, Alliance Pharma has found itself firmly back on investors' minds
  • Horizon inks Abcam deal Tip Update

    09 September 2015

    Horizon Discovery's shares have risen on news of an agreement with Aim-listed Abcam
  • Fertile performance at Genus

    08 September 2015

    A strong performance in North America offset weakness in Asia for genetics specialist Genus
  • Verseon arrives in London

    08 September 2015

    Verseon has been quick to deploy the proceeds of its Aim debut in May
  • US sales lift Dechra

    08 September 2015

    Dechra has used its traction in the US to overcome the weak euro

Register today and get...

Register today and get...
Please note terms & conditions apply